Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IGV-001 |
Synonyms | |
Therapy Description |
IGV-001 is a preparation of IGF type 1 receptor antisense oligo-treated autologous glioblastoma tumor cells, which may induce anti-tumor immune response in glioblastoma patients (PMID: 33500356). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IGV-001 | IGV001|IGV 001 | IGV-001 is a preparation of IGF type 1 receptor antisense oligo-treated autologous glioblastoma tumor cells, which may induce anti-tumor immune response in glioblastoma patients (PMID: 33500356). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|